OREANDA-NEWS. Takeda Pharmaceutical Company Limited (TSE: 4502) ("Takeda") today announced that Christophe Weber, President and Chief Executive Officer of Takeda, will make a formal presentation on January 12, local time, at the 34th Annual J.P. Morgan Healthcare Conference held in San Francisco, California. The presentation will be followed by a Q&A session.

Details of the timing, and how to access the audio webcast and presentation materials, are as follows.

Date and time Tuesday January 12, at 11:30am – 12:30pm (Pacific Standard Time)
[Wednesday January 13, at 4:30am – 5:30am (Japan Standard Time)]
Agenda
  • Presentation (25 minutes): Takeda Strategic Update

Christophe Weber, President and Chief Executive Officer
(Note: Includes updates on ENTYVIO® sales from Oct-Dec 2015, and
Takeda's direction in R&D)

  • Q&A session (25 minutes)

Christophe Weber, President and Chief Executive Officer
Andrew Plump, Chief Medical & Scientific Officer
Rudolf van Houten, acting Chief Financial Officer
Christophe Bianchi, President, Global Oncology Business Unit
Access to audio webcast http://bit.ly/1TH6bTS
? ?Registration is required in advance, so please visit the URL a few ?minutes before the presentation is scheduled to begin.
? ?In addition to a live webcast, the audio will also be available on-demand at this URL for 90 days following the event.
Access to presentation materials Presentation materials will be uploaded to Takeda's website at the same time as the presentation begins:
http://bit.ly/1O6KRFX

Note: Audio and materials are available only in English.

###

About Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda (TSE: 4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.